Specific triggers for medical consultation include achieving less than 5% body weight reduction after reaching the maintenance dose (for Wegovy, after 12 weeks at 2.4 mg as per FDA labeling), prolonged weight loss plateau despite adherence, or intolerable side effects preventing dose escalation to therapeutic levels
V c kh nng chng oxi ha cao, chm qu trnh lo ha
Nu bn ang dng Sulfonylurea hoc Insulin, hy thng bo vi bc s iu chnh liu thuc tiu ng nu cn
If you experience significant nausea, ask your provider about a modified escalation schedule
GLP-1 medications are effective for weight loss alongside diet and exercise changes in people with overweight or obesity
The compound, not the pricing page, drives the biology